A6788812
PFI-1 , ≥98% , 1403764-72-6
Synonym(s):
2-Methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydro-quinazolin-6-yl)-bezenesulfonamide;PF-06405761
CAS NO.:1403764-72-6
Empirical Formula: C16H17N3O4S
Molecular Weight: 347.39
MDL number: MFCD22580416
| Pack Size | Price | Stock | Quantity |
| 1MG | RMB95.20 | In Stock |
|
| 5MG | RMB319.20 | In Stock |
|
| 10mg | RMB431.20 | In Stock |
|
| 25MG | RMB975.20 | In Stock |
|
| 50mg | RMB1727.20 | In Stock |
|
| 100MG | RMB2678.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| storage temp. | Sealed in dry,2-8°C |
| solubility | DMSO: ≥10mg/mL |
| form | powder |
| color | white to beige |
Description and Uses
PFI 1 is a BET bromodomain inhibitor that exhibits inhibitory activity at BRD2 and BRD4. PFI-1 is a selective BET bromodomain inhibitor with activity at BRD2 (IC50 = 98 nM) and BRD4 (IC50 = 220 nM). PFI 1 induces apoptosis and G1 cell cycle arrest in BET inhibitor-sensitive cell lines (MV4;11). PFI 1 also downregulates Aurora B expression in MV4;11 cells.
PFI-1 is used as a selective protein interaction inhibitor targetting BET bromodomains, used as regulators required for efficient expression of several growth promoting and anti-apoptotic genes.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| WGK Germany | 3 |






